Treatment of myositis with etanercept (Enbrel®), a recombinant human soluble fusion protein of TNF-α type II receptor and IgG1

被引:59
作者
Sprott, H
Glatzel, M
Michel, BA
机构
[1] Univ Zurich Hosp, Dept Rheumatol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Inst Med Phys, CH-8091 Zurich, Switzerland
[3] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland
关键词
D O I
10.1093/rheumatology/keh062
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:524 / 526
页数:3
相关论文
共 4 条
[1]   Recent advances in the management of adult myositis [J].
Fam, AG .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (07) :1265-1277
[2]   Clinical experience with soluble TNF p75 receptor in rheumatoid arthritis [J].
Franklin, CM .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1999, 29 (03) :172-181
[3]  
Mikuls T R, 2001, Expert Opin Pharmacother, V2, P75, DOI 10.1517/14656566.2.1.75
[4]   Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis [J].
Shimizu, T ;
Tomita, Y ;
Son, K ;
Nishinarita, S ;
Sawada, S ;
Horie, T .
CLINICAL RHEUMATOLOGY, 2000, 19 (05) :352-359